Archer Materials LimitedASX: AXE

Archer develops early Biochip prototype

· Issued by Archer Materials Limited

Filed with ASX · · 3 pages · English

Summary by 6ix AI

Archer Materials Limited has announced the development of an early Biochip prototype for blood potassium sensing, marking a significant milestone in their technology advancement. The alpha prototype integrates the Biochip, test cartridge, and readout electronics, demonstrating stable operation and clinical-grade accuracy in potassium measurements. Archer is now progressing towards a beta prototype, expected to facilitate negotiations with MedTech companies for potential licensing deals. This development aims to enhance clinical workflows for potassium monitoring, particularly for patients with chronic kidney disease and heart failure.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Archer Materials Limited on 6ix

In the deck

Story so far

Earlier from Archer Materials

Later from Archer Materials

All Archer Materials news releases